The Korean Urological Association   Report issue

Academic/Hospital Phase 4
Founded: Seoul Korea, Republic of (1945)

Organization Overview

First Clinical Trial
2008
NCT00880672
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperplasia (Phase 4)

Inflammation (Phase 4)

Prostatic Hyperplasia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 6